We examined whether the administration of ferroptosis attenuated lung inflammation, destruction and remodeling in COPD mice by utilizing the ferroptosis inducer erastin, ferroptosis inhibitor Fer-1, HO-1 inhibitor ZnPP, and iron chelator DFO (Figure 7A). This evidence concerns the gene HMOX1 and chronic obstructive pulmonary disease.